Before joining the lab of Michel Sadelain in 2014, Justin Eyquem did a PhD in partnership with French CAR-T company Cellectis. Now principal investigator at UCSF and co-founder of Mnemo Therapeutics, Justin comes back on the journey of Cellectis and how the company re-invented itself in the 2010s.
Watch the full episode for free: [ Ссылка ]
Mnemo Therapeutics : [ Ссылка ]
